Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Yasuhisa, Sando"'
Autor:
Yuichi Sumii, Takumi Kondo, Shuntaro Ikegawa, Takuya Fukumi, Miki Iwamoto, Midori Filiz Nishimura, Hiroyuki Sugiura, Yasuhisa Sando, Makoto Nakamura, Yusuke Meguri, Takashi Matsushita, Naoki Tanimine, Maiko Kimura, Noboru Asada, Daisuke Ennishi, Yoshinobu Maeda, Ken-ichi Matsuoka
Publikováno v:
JCI Insight, Vol 8, Iss 8 (2023)
Posttransplant cyclophosphamide (PTCy) is associated with a low incidence of chronic graft-versus-host disease (cGVHD) following hematopoietic stem cell (HSC) transplantation. Previous studies have shown the important roles of B cell immunity in cGVH
Externí odkaz:
https://doaj.org/article/112390f848d8432d80e3a68f94a73c11
Autor:
Hiroyuki Sugiura, Ken‐ichi Matsuoka, Takuya Fukumi, Yuichi Sumii, Takumi Kondo, Shuntaro Ikegawa, Yusuke Meguri, Miki Iwamoto, Yasuhisa Sando, Makoto Nakamura, Tomohiro Toji, Yasuyuki Ishii, Yoshinobu Maeda
Publikováno v:
Immunity, Inflammation and Disease, Vol 9, Iss 3, Pp 721-733 (2021)
Abstract Background and Aim Chronic graft‐versus‐host disease (cGVHD) is a major cause of nonrelapse morbidity and mortality following hematopoietic stem cell transplantation (HSCT). α‐Galactosylceramide (α‐GC) is a synthetic glycolipid tha
Externí odkaz:
https://doaj.org/article/44d96308f2414d67b189aba8ad898223
Autor:
Yusuke Meguri, Takeru Asano, Takanori Yoshioka, Miki Iwamoto, Shuntaro Ikegawa, Hiroyuki Sugiura, Yuriko Kishi, Makoto Nakamura, Yasuhisa Sando, Takumi Kondo, Yuichi Sumii, Yoshinobu Maeda, Ken-ichi Matsuoka
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
CD4+Foxp3+ regulatory T cells (Tregs) play a central role in the maintenance of immune tolerance after allogeneic hematopoietic stem cell transplantation (HSCT). Tregs promptly respond to low concentrations of IL-2 through the constitutive expression
Externí odkaz:
https://doaj.org/article/42a265b21bcb45fca535e41a4d4f72df
Autor:
Makoto Nakamura, Yusuke Meguri, Shuntaro Ikegawa, Takumi Kondo, Yuichi Sumii, Takuya Fukumi, Miki Iwamoto, Yasuhisa Sando, Hiroyuki Sugiura, Noboru Asada, Daisuke Ennishi, Shuta Tomida, Emi Fukuda-Kawaguchi, Yasuyuki Ishii, Yoshinobu Maeda, Ken-ichi Matsuoka
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-17 (2021)
Abstract Posttransplantation cyclophosphamide (PTCy) has become a popular option for haploidentical hematopoietic stem cell transplantation (HSCT). However, personalized methods to adjust immune intensity after PTCy for each patient’s condition hav
Externí odkaz:
https://doaj.org/article/388351f9d0984b6baabda3767f059358
Autor:
Shuntaro Ikegawa, Yusuke Meguri, Takumi Kondo, Hiroyuki Sugiura, Yasuhisa Sando, Makoto Nakamura, Miki Iwamoto, Yoshinobu Maeda, Ken-ichi Matsuoka
Publikováno v:
Blood Advances, Vol 3, Iss 23, Pp 4081-4094 (2019)
Abstract: Graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a significant cause of morbidity and mortality. Regulatory T cells (Tregs) are critical mediators of immune tolerance after allo-HSCT.
Externí odkaz:
https://doaj.org/article/a7ac82dd0f734a32bba71b7db426f7b4
Autor:
Masaya Abe, Nobuharu Fujii, Kentaro Mizuhara, Tomohiro Urata, Yuichi Sumii, Yuki Fujiwara, Keisuke Seike, Yasuhisa Sando, Makoto Nakamura, Keiko Fujii, Kyosuke Saeki, Yusuke Meguri, Noboru Asada, Daisuke Ennishi, Hisakazu Nishimori, Ken-ichi Matsuoka, Yoshinobu Maeda
Publikováno v:
Leukemia Research Reports, Vol 15, Iss , Pp 100241- (2021)
Owing to the poor prognosis of relapsed or refractory acute lymphoblastic leukemia (ALL), hematopoietic stem cell transplantation (HSCT) followed by effective salvage therapy is required. Inotuzumab ozogamicin (INO) was developed for ALL refractory t
Externí odkaz:
https://doaj.org/article/ceb19e7707c74a5d825328162843e597
Autor:
Yasuhisa Sando, Ken-ichi Matsuoka, Yuichi Sumii, Takumi Kondo, Shuntaro Ikegawa, Hiroyuki Sugiura, Makoto Nakamura, Miki Iwamoto, Yusuke Meguri, Noboru Asada, Daisuke Ennishi, Hisakazu Nishimori, Keiko Fujii, Nobuharu Fujii, Atae Utsunomiya, Takashi Oka, Yoshinobu Maeda
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-1 (2021)
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Externí odkaz:
https://doaj.org/article/d12dcb9f3fe74a8abf10d48783a331fd
Autor:
Yui Kambara, Noboru Asada, Kaori Kondo, Yuichi Sumii, Yuki Fujiwara, Keisuke Seike, Yasuhisa Sando, Kyosuke Saeki, Hisakazu Nishimori, Keiko Fujii, Nobuharu Fujii, Ken‐ichi Matsuoka, Yoshinobu Maeda
Publikováno v:
Transfusion Medicine. 32:527-529
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::898ba58786ce3fdb627d38f291dd2724
https://doi.org/10.1111/tme.12916
https://doi.org/10.1111/tme.12916
Autor:
Nobuharu Fujii, Noboru Asada, Daisuke Ennishi, Hiroyuki Sugiura, Misako Shibakura, Takumi Kondo, Yoshinobu Maeda, Hisakazu Nishimori, Keiko Fujii, Yusuke Meguri, Yuichi Sumii, Makoto Nakamura, Yasuhisa Sando, Shuntaro Ikegawa, Miki Iwamoto, Ken-ichi Matsuoka
Publikováno v:
Bone Marrow Transplantation. 56:956-959
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f47cdac86fc185b2e8eead48b9880079
https://doi.org/10.1038/s41409-020-01100-0
https://doi.org/10.1038/s41409-020-01100-0
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.